Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14127)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2013 (publication date) through Jul 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol 2013; 19(3): 339-346 [PMID: 23372355 DOI: 10.3748/wjg.v19.i3.339] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i3/339.htm |
| Number | Citing Articles |
| 1 |
Masataka Maruno, Katsunori Imai, Yosuke Nakao, Yuki Kitano, Takayoshi Kaida, Kosuke Mima, Hiromitsu Hayashi, Yo-Ichi Yamashita, Yoshiki Mikami, Hideo Baba. Multiple hepatic inflammatory pseudotumors with elevated alpha-fetoprotein and alpha-fetoprotein lectin 3 fraction with various PET accumulations: a case report. Surgical Case Reports 2021; 7(1) doi: 10.1186/s40792-021-01188-6
|
| 2 |
Siyuan Chen, Junhong Li, Xiaodan Tan, Qi Xu, Yuncong Mo, Hongyan Qin, Lili Zhou, Lingxiu Ma, Zhixiao Wei. Clinical role of combining alpha‐fetoprotein and lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study. Journal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23262
|
| 3 |
Huaping Chen, Siyuan Chen, Shan Li, Zhijian Chen, Xuan Zhu, Meiyu Dai, Lingxi Kong, Xiaodan Lv, Zhili Huang, Xue Qin. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. Oncotarget 2017; 8(52): 90390 doi: 10.18632/oncotarget.20153
|
| 4 |
Valentina Peta, Jianhui Zhu, David M. Lubman, Samuel Huguet, Francoise Imbert-Bismutd, Gérard Bolbach, Gilles Clodic, Lucrèce Matheron, Yen Ngo, Pais Raluca, Chantal Housset, Keyvan Rezai, Thierry Poynard. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease. Clinics and Research in Hepatology and Gastroenterology 2020; 44(5): 681 doi: 10.1016/j.clinre.2019.12.010
|
| 5 |
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan, Alexandra Crăciun. Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 2023; 13(5): 816 doi: 10.3390/diagnostics13050816
|
| 6 |
Jiaxin Zhang, Guang Chen, Peng Zhang, Jiaying Zhang, Xiaoke Li, Da’nan Gan, Xu Cao, Mei Han, Hongbo Du, Yong’an Ye, Gianfranco D. Alpini. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 2020; 15(2): e0228857 doi: 10.1371/journal.pone.0228857
|
| 7 |
Hao-Guang Wan, Hao Xu, Yu-Ming Gu, Hui Wang, Wei Xu, Mao-Heng Zu. Comparison osteopontin vs AFP for the diagnosis of HCC: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014; 38(6): 706 doi: 10.1016/j.clinre.2014.06.008
|
| 8 |
Lung-Yi Mak. Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinoma. Journal of Liver Cancer 2024; 24(2): 145 doi: 10.17998/jlc.2024.08.03
|
| 9 |
Hao Xing, Yi-Jie Zheng, Jun Han, Han Zhang, Zhen-Li Li, Wan-Yee Lau, Feng Shen, Tian Yang. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis. Hepatobiliary & Pancreatic Diseases International 2018; 17(6): 487 doi: 10.1016/j.hbpd.2018.09.009
|
| 10 |
Rong Wen, Yuting Peng, Yiqiong Liang, Yuquan Wu, Haiyuan Li, Yanxia Chen, Yan Qin, Zhiyuan Wen, Huanyu Cui, Yun He, Hong Yang. CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients. Ultrasound in Medicine & Biology 2024; 50(11): 1739 doi: 10.1016/j.ultrasmedbio.2024.08.003
|
| 11 |
Elisabetta Degasperi, Riccardo Perbellini, Roberta D’Ambrosio, Sara Colonia Uceda Renteria, Ferruccio Ceriotti, Alberto Perego, Corinna Orsini, Marta Borghi, Massimo Iavarone, Mariangela Bruccoleri, Alessandro Rimondi, Annalisa De Silvestri, Angelo Sangiovanni, Pietro Lampertico. Prothrombin induced by vitamin K absence or antagonist‐II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C‐related cirrhosis treated with direct‐acting antiviral agents. Alimentary Pharmacology & Therapeutics 2022; 55(3): 350 doi: 10.1111/apt.16685
|
| 12 |
Clemens Schotten, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip Johnson, Heiner Wedemeyer, Jan Best. GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals 2021; 14(8): 735 doi: 10.3390/ph14080735
|
| 13 |
Tetsuhiro Chiba, Eiichiro Suzuki, Tomoko Saito, Sadahisa Ogasawara, Yoshihiko Ooka, Akinobu Tawada, Atsushi Iwama, Osamu Yokosuka. Biological features and biomarkers in hepatocellular carcinoma. World Journal of Hepatology 2015; 7(16): 2020-2028 doi: 10.4254/wjh.v7.i16.2020
|
| 14 |
Keun Soo Ahn, Daniel R. O’Brien, Yong Hoon Kim, Tae-Seok Kim, Hiroyuki Yamada, Joong-Won Park, Sang-Jae Park, Seoung Hoon Kim, Cheng Zhang, Hu Li, Koo Jeong Kang, Lewis R. Roberts. Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma. Liver Cancer 2021; 10(6): 593 doi: 10.1159/000516957
|
| 15 |
Jia Fan, Yu Chen, Dan Zhang, Juan Yao, Zijun Zhao, Yao Jiang, Yiqin Li, Yongcan Guo. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Surgical Oncology 2020; 34: 245 doi: 10.1016/j.suronc.2020.05.002
|
| 16 |
Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Ying He, Magdalena Swiatek‐de Lange, David Morgenstern, Henry Lik‐Yuen Chan. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study. Hepatology Communications 2022; 6(4): 679 doi: 10.1002/hep4.1847
|
| 17 |
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 281 doi: 10.1016/B978-0-323-98807-0.00005-3
|
| 18 |
Sang Joon Park, Jae Young Jang, Soung Won Jeong, Young Kyu Cho, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Hae In Bang. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Medicine 2017; 96(11): e5811 doi: 10.1097/MD.0000000000005811
|
| 19 |
Stijn Van Hees, Peter Michielsen, Thomas Vanwolleghem. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(37): 8271-8282 doi: 10.3748/wjg.v22.i37.8271
|
| 20 |
Tung-Hung Su, Cheng-Yuan Peng, Shan-Han Chang, Tai-Chung Tseng, Chun-Jen Liu, Chi-Ling Chen, Chen-Hua Liu, Hung-Chih Yang, Pei-Jer Chen, Jia-Horng Kao. Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis. Journal of the Formosan Medical Association 2022; 121(3): 703 doi: 10.1016/j.jfma.2021.08.003
|
| 21 |
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. Journal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
|
| 22 |
Suresh K. Kailasa, Vaibhavkumar N. Mehta, Jigneshkumar V. Rohit. Miniaturized Analytical Devices. 2022; : 1 doi: 10.1002/9783527827213.ch1
|
| 23 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 24 |
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565: 119977 doi: 10.1016/j.cca.2024.119977
|
| 25 |
Han Ah Lee, Yoo Ra Lee, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Kwan Soo Byun, Yeon Seok Seo. <i>Lens culinaris</i> agglutinin-reactive fraction of alpha-fetoprotein improves diagnostic accuracy for hepatocellular carcinoma. World Journal of Gastroenterology 2021; 27(28): 4687-4696 doi: 10.3748/wjg.v27.i28.4687
|
| 26 |
Oraphan Jitpraphawan, Witchakorn Ruamtawee, Mala Treewatchareekorn, Supatsri Sethasine. Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study. World Journal of Gastroenterology 2024; 30(17): 2343-2353 doi: 10.3748/wjg.v30.i17.2343
Abstract(529) |
Core Tip(642) |
Full Article(HTML)(2071)
|
Full Article with Cover (PDF)-2253K(113)
|
Audio-1483K(16)
|
Peer-Review Report-169K(77)
|
Answering Reviewers-52K(63)
|
Supplementary Material-71K(77)
|
Full Article (PDF)-866K(152)
|
Full Article (XML)-144K(75)
|
Times Cited (4)
|
Total Visits (6194)
|
Open
|
| 27 |
Meng Wu, Haijia Yu, Siwen Pang, Aie Liu, Jianhua Liu. Application of CT-based radiomics combined with laboratory tests such as AFP and PIVKA-II in preoperative prediction of pathologic grade of hepatocellular carcinoma. BMC Medical Imaging 2025; 25(1) doi: 10.1186/s12880-025-01588-2
|
| 28 |
Ting Wang, Kun-He Zhang. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01316
|
| 29 |
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. The Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
|
| 30 |
Minghui Wang, Zhijun Zhang, Deng Pan, Zhigang Xin, Fan Bu, Yue Zhang, Qingwu Tian, Xiaodong Feng. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer. Bioscience Reports 2021; 41(7) doi: 10.1042/BSR20211115
|
| 31 |
Wan-Ju Xu, Bao-Li Guo, Yu-Gang Han, Lei Shi, Wan-Shan Ma. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels. Tumor Biology 2014; 35(12): 12069 doi: 10.1007/s13277-014-2506-8
|
| 32 |
Neeral L. Shah, Nicolas M. Intagliata, Patrick G. Northup, Curtis K. Argo, Stephen H. Caldwell. Procoagulant therapeutics in liver disease: a critique and clinical rationale. Nature Reviews Gastroenterology & Hepatology 2014; 11(11): 675 doi: 10.1038/nrgastro.2014.121
|
| 33 |
Jinqi Tu, Bo Wang, Xiaoming Wang, Kugeng Huo, Wanting Hu, Rongli Zhang, Jinyao Li, Shijie Zhu, Qionglin Liang, Shuxin Han. Current status and new directions for hepatocellular carcinoma diagnosis. Liver Research 2024; 8(4): 218 doi: 10.1016/j.livres.2024.12.001
|
| 34 |
Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing. Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma. Clinical and Molecular Hepatology 2025; 31(1): 196 doi: 10.3350/cmh.2024.0527
|
| 35 |
Fei Xu, Lulu Zhang, Wenting He, Di Song, Xiaomeng Ji, Jianyong Shao, Jie Mei. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/8868370
|
| 36 |
J.F. Schlaak. Labordiagnostik bei primärem Leberzellkarzinom. Der Gastroenterologe 2014; 9(2): 138 doi: 10.1007/s11377-013-0839-2
|
| 37 |
Xiao-Qiong Tang, Hong Li, Li-Bo Yan, Ling-Yun Zhou, En-Qiang Chen, Miao Liu, Dong-Mei Zhang, Hong Tang. Diagnostic Value of PIVKA-II in Detecting Hepatocellular Carcinoma. Future Virology 2017; 12(5): 259 doi: 10.2217/fvl-2017-0017
|
| 38 |
Shujing Huang, Feifei Jiang, Ying Wang, Yanhua Yu, Siqian Ren, Xiaowei Wang, Peng Yin, Jinli Lou. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients. Tumor Biology 2017; 39(6): 101042831770576 doi: 10.1177/1010428317705763
|
| 39 |
Jiang-feng Xu, Xi-yu Liu. PIVKA-II is an independent prognostic factor for overall survival of HCC patients and maybe associated with epithelial-mesenchymal transition. Journal of Hepatology 2015; 63(4): 1040 doi: 10.1016/j.jhep.2015.04.031
|
| 40 |
Lili Wang, Xiulan Yang, Jinhuan Wang, Guoying Yu. Predictive value of PIVKA-II and AFP for the non-objective response of HBV-associated hepatocellular carcinoma after transarterial chemoembolization: a prospective study. European Journal of Gastroenterology & Hepatology 2023; 35(12): 1410 doi: 10.1097/MEG.0000000000002663
|
| 41 |
Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014; 26: 327 doi: 10.1016/j.meegid.2014.06.014
|
| 42 |
Long Liu, Qi Wang, Xiaohong Zhao, Yuxi Huang, Yuyi Feng, Yu Zhang, Zheping Fang, Shaowei Li. Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1131892
|
| 43 |
See-Lok Ho, Di Xu, Man Shing Wong, Hung-Wing Li. Direct and multiplex quantification of protein biomarkers in serum samples using an immuno-magnetic platform. Chemical Science 2016; 7(4): 2695 doi: 10.1039/C5SC04115E
|
| 44 |
Kazuo Tarao, Akito Nozaki, Hirokazu Komatsu, Tatsuji Komatsu, Masataka Taguri, Katsuaki Tanaka, Makoto Chuma, Kazushi Numata, Shin Maeda. Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases. World Journal of Hepatology 2020; 12(11): 1046-1054 doi: 10.4254/wjh.v12.i11.1046
|
| 45 |
Jinhui Zhu, Kai Yu, Ramon Andrade de Mello. International Manual of Oncology Practice. 2015; : 327 doi: 10.1007/978-3-319-21683-6_16
|
| 46 |
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases. Comparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
|
| 47 |
Hao Ma, Xiaoying Sun, Lei Chen, Weina Cheng, Xiao Xia Han, Bing Zhao, Chengyan He. Multiplex Immunochips for High-Accuracy Detection of AFP-L3% Based on Surface-Enhanced Raman Scattering: Implications for Early Liver Cancer Diagnosis. Analytical Chemistry 2017; 89(17): 8877 doi: 10.1021/acs.analchem.7b01349
|
| 48 |
Chenjun Huang, Meng Fang, Xiao Xiao, Hong Wang, Zhiyuan Gao, Jun Ji, Lijuan Liu, Erli Gu, Ya Li, Mengmeng Wang, Chunfang Gao. Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study. Liver International 2022; 42(1): 210 doi: 10.1111/liv.15082
|
| 49 |
Makoto Meguro, Toru Mizuguchi, Toshihiko Nishidate, Kenji Okita, Masayuki Ishii, Shigenori Ota, Tomomi Ueki, Emi Akizuki, Koichi Hirata. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World Journal of Gastroenterology 2015; 21(16): 4933-4945 doi: 10.3748/wjg.v21.i16.4933
|
| 50 |
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
|
| 51 |
Jolitta S. J. Britto, Xinwei Guan, Thi Kim Anh Tran, Zhihao Lei, Rohan Bahadur, Vaishwik Patel, Xiangwei Zhang, Sharon L. Wong, Ajayan Vinu. Emerging Multifunctional Carbon‐Nanomaterial‐Based Biosensors for Cancer Diagnosis. Small Science 2024; 4(3) doi: 10.1002/smsc.202300221
|
| 52 |
Aurora NICOLOSI, Rinaldo PELLICANO, Gian Paolo CAVIGLIA. Surveillance of cirrhotic patients using the protein induced by vitamin K absence or antagonist II (PIVKA-II). Minerva Medica 2022; 113(1) doi: 10.23736/S0026-4806.21.07952-0
|
| 53 |
Ghassan K. Abou-Alfa, Lin Wu, Augusto Villanueva. Novel Non-Protein Biomarkers for Early Detection of Hepatocellular Carcinoma. Engineering 2021; 7(10): 1369 doi: 10.1016/j.eng.2021.02.020
|
| 54 |
Ji De, Yi Shen, Jinyu Qin, Li Feng, Yiping Wang, Li Yang. A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma. Medicine 2016; 95(17): e3448 doi: 10.1097/MD.0000000000003448
|
| 55 |
ImanM.S El-Bagory, AmalA El-Aleem, NessrenM.B El-Deen Mohamed, SalwaA El-Latif Shendy. Serum level of cluster of differentiation 166 as novel biomarker in hepatocellular carcinoma. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(3): 573 doi: 10.4103/sjamf.sjamf_30_19
|
| 56 |
Wenling Zhang, Yumei Huang, Jian Xu. Clinical Molecular Diagnostics. 2021; : 261 doi: 10.1007/978-981-16-1037-0_21
|
| 57 |
Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang. Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients. Heliyon 2023; 9(11): e21906 doi: 10.1016/j.heliyon.2023.e21906
|
| 58 |
Lorico DS. Lapitan, Mariusz Pietrzak, Marek Krawczyk, Elżbieta Malinowska. Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma. Sensors and Actuators B: Chemical 2023; 393: 134209 doi: 10.1016/j.snb.2023.134209
|
| 59 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 60 |
Abdulrahman Hatawsh, Roya Hadi Al-Haddad, Ukamaka Gladys Okafor, Lamis M. Diab, Nino Dekanoidze, Adeniyi Ayinde Abdulwahab, Osama A. Mohammed, Ahmed S. Doghish, Rewan Moussa, Hanan Elimam. Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma. Medical Oncology 2024; 41(12) doi: 10.1007/s12032-024-02538-8
|
| 61 |
Hongyu Liu, Baoguo Li. The functional role of exosome in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2018; 144(11): 2085 doi: 10.1007/s00432-018-2712-7
|
| 62 |
Xiaoyan Yi, Shuang Yu, Yixi Bao. Alpha-fetoprotein-L3 in hepatocellular carcinoma: A meta-analysis. Clinica Chimica Acta 2013; 425: 212 doi: 10.1016/j.cca.2013.08.005
|
| 63 |
Alain Wuethrich, Joselito P. Quirino. A decade of microchip electrophoresis for clinical diagnostics – A review of 2008–2017. Analytica Chimica Acta 2019; 1045: 42 doi: 10.1016/j.aca.2018.08.009
|
| 64 |
Ji Won Han, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Tatsuo Kanda. Whole blood viscosity is associated with extrahepatic metastases and survival in patients with hepatocellular carcinoma. PLOS ONE 2021; 16(12): e0260311 doi: 10.1371/journal.pone.0260311
|
| 65 |
Jiaming Zeng, Weiqi Rong, Bo Meng, Linlin Zheng, Tao Peng, Rui Zhai, You Jiang, Ting Xiao, Xiang Fang, Yong Zhang, Yang Zhao, Xinhua Dai. Integrated plasma proteomics and N‐glycoproteomics reveals alterations in the N‐glycosylation in Chinese hepatocellular carcinoma patients. PROTEOMICS – Clinical Applications 2024; 18(4) doi: 10.1002/prca.202300029
|
| 66 |
静 卢. Research Progress on Serological Markers for Early Diagnosis of Liver Cancer. Advances in Clinical Medicine 2025; 15(04): 139 doi: 10.12677/acm.2025.154911
|
| 67 |
Aiying Zhang, Sven Skog, Shengqi Wang, Yang Ke, Yonghong Zhang, Kang Li, Ellen He, Ning Li. A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index. Scientific Reports 2016; 6(1) doi: 10.1038/srep31132
|
| 68 |
Jan Best, Lars P. Bechmann, Jan-Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip Johnson, Ali Canbay. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology 2020; 18(3): 728 doi: 10.1016/j.cgh.2019.11.012
|
| 69 |
Vincent L. Chen, Pratima Sharma. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 577 doi: 10.1016/j.cld.2020.07.001
|
| 70 |
Qingzhu Zheng, Xiaohong Xu, Jiamiao Weng, Mingjie Li, Bin Li, Yingping Cao. The elevated expression of serum glutathione reductase in hepatocellular carcinoma and its role in assessing the therapeutic efficacy and prognosis of transarterial chemoembolization. Free Radical Biology and Medicine 2024; 221: 225 doi: 10.1016/j.freeradbiomed.2024.05.043
|
| 71 |
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T. Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy. Liver International 2020; 40(8): 1987 doi: 10.1111/liv.14475
|
| 72 |
Heqing Huang, Min Zhang, Hong Lu, Yiling Chen, Weijie Sun, Jinghan Zhu, Zutao Chen. Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13332-0
|
| 73 |
Junghwan Lee, Su Bee Park, Soyoung Byun, Ha Il Kim, Do Young Kim. Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance. PLOS ONE 2022; 17(9): e0274747 doi: 10.1371/journal.pone.0274747
|
| 74 |
Yongwu Chen, Xiuli Yang, Yanfei Shao, Hongying Zhao, Jinying Jiang, Ping Huang, Yi Lu, Zixue Xuan. Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study. Annals of Hepatology 2023; 28(4): 101099 doi: 10.1016/j.aohep.2023.101099
|
| 75 |
June Young Seo, Ijin Joo, Jeong Hee Yoon, Hyo Jin Kang, Sewoo Kim, Jong Hyo Kim, Chulkyun Ahn, Jeong Min Lee. Deep learning-based reconstruction of virtual monoenergetic images of kVp-switching dual energy CT for evaluation of hypervascular liver lesions: Comparison with standard reconstruction technique. European Journal of Radiology 2022; 154: 110390 doi: 10.1016/j.ejrad.2022.110390
|
| 76 |
Honglei Feng, Bole Li, Ze Li, Qian Wei, Li Ren. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08138-3
|
| 77 |
Manar M. Ismail, Heba K. Morsi, Nahla A. B. Abdulateef, Maissa K. Noaman, Ghada A. Abou El-Ella. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance. Scandinavian Journal of Clinical and Laboratory Investigation 2017; 77(3): 175 doi: 10.1080/00365513.2017.1286684
|
| 78 |
JIAN ZHANG, CHUXIAO SHAO, QINGYUN ZHOU, YIMIN ZHU, JINDE ZHU, CHAOYONG TU. Diagnostic accuracy of serum squamous cell carcinoma antigen and squamous cell carcinoma antigen-immunoglobulin M for hepatocellular carcinoma: A meta-analysis. Molecular and Clinical Oncology 2015; 3(5): 1165 doi: 10.3892/mco.2015.600
|
| 79 |
Famei Qi, Aihua Zhou, Li Yan, Xiumei Yuan, Danni Wang, Ruoyun Chang, Yujun Zhang, Funa Shi, Xiaomei Han, Jinxia Hou, Lianhua Wei, Xu Zhang. The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2020; 34(5) doi: 10.1002/jcla.23158
|
| 80 |
Chenjun Huang, Xiao Xiao, Lin Zhou, Fuxiang Chen, Jianyi Wang, Xiaobo Hu, Chunfang Gao. Chinese expert consensus statement on the clinical application of AFP/AFP‐L3%/DCP using GALAD and GALAD‐like algorithm in HCC. Journal of Clinical Laboratory Analysis 2023; 37(23-24) doi: 10.1002/jcla.24990
|
| 81 |
Mahmoud M. Kamel, Mohamed F. Saad, Amal A. Mahmoud, Awatief A. Edries, Ahmed S. Abdel-Moneim. Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma. Microbial Pathogenesis 2014; 77: 31 doi: 10.1016/j.micpath.2014.10.009
|
| 82 |
Yanhui Shi, Hongli Yang, Xue Bai, Xiaoyan Liu, Qiang Li, Wenjun Du. Female and diabetes are risk factors for alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II negative in hepatocellular carcinoma. Medicine 2024; 103(42): e40100 doi: 10.1097/MD.0000000000040100
|
| 83 |
Mostafa A. Sharafeldin, Reda A. Suef, Adel A. Mousa, Dina H. Ziada, Mohamed M. S. Farag. Serum miRNA-101 expression signature as non-invasive diagnostic biomarker for Hepatitis C virus—associated hepatocellular carcinoma in Egyptian patients. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-81207-2
|
| 84 |
Haiqing Sun, Ning Liu, Jinli Lou. Diagnostic value of serum STIP1 in HCC and AFP-negative HCC. Laboratory Medicine 2024; 55(6): 700 doi: 10.1093/labmed/lmae033
|
| 85 |
E-Na Qian, Shuang-Yin Han, Song-Ze Ding, Xun Lv. Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0332-3
|
| 86 |
Yu‑Xue Gao, Tong‑Wang Yang, Ji‑Ming Yin, Peng‑Xiang Yang, Bu‑Xin Kou, Meng‑Yin Chai, Xiao‑Ni Liu, De‑Xi Chen. Progress and prospects of biomarkers in�primary liver cancer (Review). International Journal of Oncology 2020; doi: 10.3892/ijo.2020.5035
|
| 87 |
Si-Yu Liu, Chao Li, Li-Yang Sun, Ming-Cheng Guan, Li-Hui Gu, Dong-Xu Yin, Lan-Qing Yao, Lei Liang, Ming-Da Wang, Hao Xing, Hong Zhu, Timothy M. Pawlik, Wan Yee Lau, Feng Shen, Xiang-Min Tong, Tian Yang. ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1018396
|